Placebo-Controlled Study of Pimozide Augmentation of Fluoxetine in Body Dysmorphic Disorder
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Although body dysmorphic disorder often responds to serotonin reuptake inhibitors (SRIs), most patients do not respond or respond only partially. However, placebo-controlled studies of augmentation of SRIs have not been done. Furthermore, although 40%-50% of patients are delusional, studies of antipsychotic medications have not been done. METHOD: Twenty-eight patients with body dysmorphic disorder or its delusional variant participated in an 8-week, placebo-controlled, double-blind, parallel-group study of pimozide augmentation of fluoxetine. RESULTS: Pimozide was not more effective than placebo: two (18.2%) of 11 subjects responded to pimozide and three (17.6%) of 17 subjects responded to placebo. There was no significant effect of baseline delusionality on endpoint severity of body dysmorphic disorder. Delusionality did not decrease significantly more with pimozide than placebo. CONCLUSIONS: Pimozide augmentation of fluoxetine treatment for body dysmorphic disorder was not more effective than placebo, even in more delusional patients. Further studies of augmentation for SRIs are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brown assessment of beliefs scale: Reliability and validity
Eisen, J. L., Phillips, K. A., Baer, L., Beer, D. A., Atala, K. D., & Rasmussen, S. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.102 · Cited by 705 · cited 2×
“Addi- Measure Pimozide (N=11) Placebo (N=17) AnalysisBaseline Endpoint Baseline Endpoint Mean SD Mean SD Mean SD Mean SD F (df=1, 25) p Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder score 27.2 5.7 23.9 6.6 29.6 6.3 28.0 7.8 0.97 0.34 Brown Assessment of Beliefs Scale scorea 15.0 5.4 13.5…”
MethodSelf-citation
Cited by
Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?
Phillips, K. A., Stein, D. J., Rauch, S. L., Hollander, E., Fallon, B. A., Barsky, A., Fineberg, N., Mataix-Cols, D., Ferrão, Y. A., Saxena, S., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20705 · Cited by 347
Self-citationBody Dysmorphic Disorder and Cosmetic Surgery
Crerand, C. E., Franklin, M. E., & Sarwer, D. B. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000242500.28431.24 · Cited by 265
Phillips, K. A., & Hollander, E. (2008) · Body Image · doi:10.1016/j.bodyim.2007.12.003 · Cited by 214
“BDD appears far more common than this in inpatient and outpatient settings (Phillips, 2005a).”
BackgroundInfluentialSelf-citationVeale, D., Anson, M., Miles, S., Pieta, M., Costa, A., & Ellison, N. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000360740 · Cited by 179
Veale, D., Miles, S., Smallcombe, N., Ghezai, H., Goldacre, B., & Hodsoll, J. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0317-5 · Cited by 162
“The same guidelines did not recommend adding an antipsychotic to a SSRI for people with Body Dysmorphic Disorder (BDD) on the basis of one negative trial with pimozide in those resistant to a SSRI [2].”
Background
Metadata
- Authors
- Phillips, K. A.
- Venue
- American Journal of Psychiatry
- Published
- 2005-02-01
- Volume
- 162
- Issue
- 2
- Pages
- 377-379
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1964945065
- Cited by
- 122
- References
- 1
- FWCI
- 15.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.